Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hanief Sofi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Blood Advances|January 24, 2022
MicroRNA-31 regulates T-cell metabolism via HIF1α and promotes chronic GVHD pathogenesis in miceYongxia Wu, Corey Mealer, Steven Schutt, et al.
The Journal of Clinical Investigation|May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host diseaseM Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
JCI Insight|May 19, 2017
Ceramide synthesis regulates T cell activity and GVHD developmentM Hanief Sofi, Jessica Heinrichs, Mohammed Dany, et al.
Cellular & Molecular Immunology|January 27, 2021
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell functionYongxia Wu, Chih-Hang Anthony Tang, Corey Mealer, et al.
Cell Reports|May 5, 2021
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell responseSilvia Vaena, Paramita Chakraborty, Han Gyul Lee, et al.
Blood Advances|February 28, 2018
Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in miceSteven D Schutt, Yongxia Wu, Chih-Hang Anthony Tang, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Blood Advances|January 24, 2022
MicroRNA-31 regulates T-cell metabolism via HIF1α and promotes chronic GVHD pathogenesis in miceYongxia Wu, Corey Mealer, Steven Schutt, et al.
The Journal of Clinical Investigation|May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host diseaseM Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
JCI Insight|May 19, 2017
Ceramide synthesis regulates T cell activity and GVHD developmentM Hanief Sofi, Jessica Heinrichs, Mohammed Dany, et al.
Cellular & Molecular Immunology|January 27, 2021
STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell functionYongxia Wu, Chih-Hang Anthony Tang, Corey Mealer, et al.
Cell Reports|May 5, 2021
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell responseSilvia Vaena, Paramita Chakraborty, Han Gyul Lee, et al.
Blood Advances|February 28, 2018
Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in miceSteven D Schutt, Yongxia Wu, Chih-Hang Anthony Tang, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Pageof 3